MMSI Announces Commencement of Patient Enrollment in PREEMIE Study

Merit Medical Systems, Inc. (MMSI) , on Monday, announced the enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder System for the treatment of patent ductus arteriosus (PDA) in premature infants (PREEMIE study). The PREEMIE study is an Investigational Device Exemption study.It should be noted that the Bloom Micro Occluder System is not currently approved to treat PDA.MMSI plans to enroll at least 55 premature infants with hemodynamically significant or large PDA ...